We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
(-2.6%)
Cap. Flow
-$4.15B
Cap. Flow
% of AUM
-9.34%
Top 10 Holdings %
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
ExxonMobil
XOM
|
+$302M |
| 3 |
Amazon
AMZN
|
+$291M |
| 4 |
Citigroup
C
|
+$253M |
| 5 |
Shopify
SHOP
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$312M |
| 3 |
JPMorgan Chase
JPM
|
+$285M |
| 4 |
AT&T
T
|
+$191M |
| 5 |
Dollar General
DG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Financials | 15.61% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Industrials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Lennar Class A
LEN
$20.4B
| $32.4M | 0.07% |
370,114
-140,927
| -28% | -$11.4M |
|
302
Ecolab
ECL
$75.6B
| $32.4M | 0.07% |
222,540
-143,512
| -39% | -$21.1M |
|
303
PUT
Tesla
TSLA
$1.24T
| $32.4M | 0.07% |
262,700
+233,200
| +791% | +$44.2M |
|
304
Alexandria Real Estate Equities
ARE
$8.88B
| $32.3M | 0.07% |
222,002
-438,167
| -66% | -$63.4M |
|
305
Dow Inc
DOW
$21.6B
| $32.1M | 0.07% |
636,144
+617,530
| +3,318% | +$30.2M |
|
306
iShares Russell 2000 ETF
IWM
$80.9B
| $32M | 0.07% |
183,391
+126,109
| +220% | +$22.4M |
|
|
DISH
307
DELISTED
DISH Network Corp.
DISH
| $31.8M | 0.07% |
2,268,355
+1,583,537
| +231% | +$23.4M |
|
|
AAWW
308
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $31.7M | 0.07% |
314,874
+62,076
| +25% | +$6.22M |
|
309
Avient
AVNT
$3.45B
| $31.7M | 0.07% |
+938,749
| New | +$30.9M |
|
310
Endava
DAVA
$141M
| $31.4M | 0.07% |
410,433
-52,735
| -11% | -$3.92M |
|
311
Icon
ICLR
$12.8B
| $31.4M | 0.07% |
+161,541
| New | +$32M |
|
312
New Fortress Energy
NFE
$101M
| $31.3M | 0.07% |
737,894
+695,771
| +1,652% | +$33.6M |
|
313
Cardinal Health
CAH
$53.4B
| $31.3M | 0.07% |
406,577
-853,063
| -68% | -$64.8M |
|
314
Cooper Companies
COO
$13.7B
| $31.1M | 0.07% |
+376,012
| New | +$27.7M |
|
315
Tenaris
TS
$29.1B
| $31.1M | 0.07% |
+883,433
| New | +$28.3M |
|
316
Petrobras
PBR
$121B
| $30.8M | 0.07% |
2,889,602
+2,258,525
| +358% | +$27.3M |
|
317
Rogers Corp
ROG
$2.33B
| $30.6M | 0.07% |
256,625
+188,149
| +275% | +$29.2M |
|
318
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $30.6M | 0.07% |
368,800
-1,080,600
| -75% | -$87.5M |
|
319
CALL
Microsoft
MSFT
$2.84T
| $30.6M | 0.07% |
127,600
+59,800
| +88% | +$14.4M |
|
320
Freshpet
FRPT
$2.83B
| $30.4M | 0.07% |
575,516
+165,906
| +41% | +$9.87M |
|
|
NEWR
321
DELISTED
New Relic, Inc.
NEWR
| $30.3M | 0.07% |
536,217
-3,719
| -0.7% | -$210K |
|
322
Dave & Buster's
PLAY
$343M
| $30.2M | 0.07% |
853,374
+325,260
| +62% | +$11.8M |
|
323
ResMed
RMD
$28.3B
| $30M | 0.07% |
144,184
+39,768
| +38% | +$8.74M |
|
324
iShares 0-1 Year Treasury Bond ETF
SHV
$20.7B
| $30M | 0.07% |
+273,000
| New | +$30M |
|
325
Biohaven
BHVN
$2.16B
| $29.9M | 0.07% |
2,157,767
+840,808
| +64% | +$11.9M |
|
Similar funds
Marshall Wace's Q4 2022 Portfolio in Review
As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.
- Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
- Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
- Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
- Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
- Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
- Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.
Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.